Shenzhen Kingsense Electronics Co., Ltd. (hereinafter referred to as “Kingsense Electronics”) recently announced that its two core technologies, “Integrated Weak Electrical Signal Filtering and Amplification Circuit” and “DC-Coupled Differential Front-End Amplifier Circuit,” have been granted invention patents by the China National Intellectual Property Administration (Patent Numbers: ZL 2020 1 0329208.3 and ZL 2020 1 0329210.0). These breakthroughs highlight the company’s technical expertise in bioelectric sensing integrated circuit design and reinforce its competitive edge in future product development.

Kingsense Electronics’ Granted Invention Patent Certificates

Focusing on Weak Signal Sensing, Breaking Through Technical Barriers
     Bioelectric sensing technology is widely used in medical electronics, wearable health monitoring, brain-computer interfaces (BCI), and other fields. Its core challenge lies in the high-precision acquisition and processing of weak bioelectric signals. The newly patented technologies address these critical demands:

·    Integrated Weak Electrical Signal Filtering and Amplification Circuit: This innovation combines filtering and amplification circuitry to significantly improve signal-to-noise ratios, resolving signal distortion caused by noise interference in traditional circuits. It enables precise detection of weak bioelectric signals such as electrocardiograms (ECG), electromyograms (EMG), and electroencephalograms (EEG).

·    DC-Coupled Differential Front-End Amplifier Circuit: Utilizing DC coupling and differential input techniques, this circuit reduces signal drift and enhances anti-interference capabilities, providing stable and reliable front-end support for high-sensitivity bioelectric sensors. Applications extend to emerging fields like dynamic glucose monitoring and EMG signal analysis.

Building Patent Barriers to Drive Industry Innovation
     The granting of these patents marks a milestone in Kingsense Electronics’ advancements in integrated circuit design and bioelectric sensing chip technologies. The company remains committed to innovation-driven growth, supported by sustained R&D investments and a multi-layered intellectual property portfolio covering invention patents, IC layout designs, and utility model patents.

     According to the R&D team, the patented technologies enable sensor chips to achieve higher signal acquisition accuracy in wearable scenarios while optimizing power consumption and miniaturization. These advancements will accelerate the adoption of intelligent health monitoring products and brain-computer interface devices.

     Moving forward, Kingsense Electronics will intensify its innovation efforts to commercialize high-quality technological achievements. The company aims to deliver more precise and reliable bioelectric signal acquisition chip solutions globally, advancing its vision of “Improving Lives Through Technology.”

About Shenzhen Kingsense Electronics Co., Ltd.
     Shenzhen Kingsense Electronics Co., Ltd. is a high-tech enterprise specializing in bioelectric sensing chip design and development. The company provides cutting-edge chip products and system solutions for bioelectric sensing, wearable health, and brain-computer interface applications. Leveraging years of expertise in biomedical sensing circuit and system design, Sinsemilla has earned broad market recognition through continuous innovation and exceptional service.

     For more information, visit the official website: www.ks-chip.com.